Theravance Biopharma, Inc. (TBPH)
20.02
-0.72
(-3.47%)
USD |
NASDAQ |
Jan 23, 11:59
Theravance Biopharma Research and Development Expense (TTM): 37.97M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 260.35M |
| Perspective Therapeutics, Inc. | 61.22M |
| Skye Bioscience, Inc. | 38.14M |
| Kyntra Bio, Inc. | 23.12M |
| Myomo, Inc. | 6.879M |